ArticleBMC neuroscience2015

Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia.

Jia Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.